{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:48:53Z","timestamp":1762501733411,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bbrep.2022.101239","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T12:22:52Z","timestamp":1646137372000},"page":"101239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["TGF-\u03b21 increases cellular invasion of colorectal neuroendocrine carcinoma cell line through partial epithelial-mesenchymal transition"],"prefix":"10.1016","volume":"30","author":[{"given":"Norihiko","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9204-6393","authenticated-orcid":false,"given":"Seiichi","family":"Shinji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Shichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2627-2859","authenticated-orcid":false,"given":"Ryo","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-7741","authenticated-orcid":false,"given":"Hiromichi","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Yonaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2022.101239_bib1","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrep.2022.101239_bib2","first-page":"873","article-title":"Different expression levels of lumican in human carcinoid tumor and neuroendocrine cell carcinoma","volume":"26","author":"Shinji","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrep.2022.101239_bib3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbrep.2022.101239_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbrep.2022.101239_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/ERC-15-0119","article-title":"Other Knowledge Network members, Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms","volume":"22","author":"Heetfeld","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbrep.2022.101239_bib6","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1111\/cas.14221","article-title":"Establishment and characterization of a novel neuroendocrine carcinoma cell line derived from a human ascending colon tumor","volume":"110","author":"Shinji","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2022.101239_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cell.2004.07.011","article-title":"Epithelial-mesenchymal transitions: twist in development and metastasis","volume":"118","author":"Kang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2022.101239_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1053\/j.gastro.2006.06.016","article-title":"A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer","volume":"131","author":"Spaderna","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrep.2022.101239_bib9","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1101\/gad.225334.113","article-title":"Epithelial-mesenchymal plasticity in carcinoma metastasis","volume":"27","author":"Tsai","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrep.2022.101239_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9120171","article-title":"Regulation of EMT in colorectal cancer: a culprit in metastasis","volume":"9","author":"Vu","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2022.101239_bib11","first-page":"357","article-title":"Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis","volume":"29","author":"Shinji","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrep.2022.101239_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/modpathol.3800018","article-title":"Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly","volume":"17","author":"Arai","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbrep.2022.101239_bib13","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.3748\/wjg.v24.i33.3749","article-title":"Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line","volume":"24","author":"Gock","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrep.2022.101239_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2217\/epi-2017-0041","article-title":"Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer","volume":"9","author":"Fesler","year":"2017","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbrep.2022.101239_bib15","doi-asserted-by":"crossref","first-page":"19369","DOI":"10.1038\/s41598-019-55867-4","article-title":"Highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage","volume":"9","author":"Sasaki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2022.101239_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102976","article-title":"FGFR4 inhibitor BLU9931 attenuates pancreatic cancer cell proliferation and invasion while inducing senescence: evidence for senolytic therapy potential in pancreatic cancer","volume":"12","author":"Sasaki","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2022.101239_bib17","doi-asserted-by":"crossref","first-page":"34719","DOI":"10.18632\/oncotarget.26176","article-title":"H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells","volume":"9","author":"Sasaki","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2022.101239_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2022.101239_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.ctdb.2014.11.021","article-title":"Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity","volume":"112","author":"Savagner","year":"2015","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bbrep.2022.101239_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2018.07.001","article-title":"Hybrid epithelial\/mesenchymal phenotype(s): the \u2018fittest\u2019 for metastasis?","volume":"1870","author":"Jolly","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrep.2022.101239_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030623","article-title":"Hybrid epithelial\/mesenchymal state in cancer metastasis: clinical significance and regulatory mechanisms","volume":"9","author":"Liao","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbrep.2022.101239_bib22","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1073\/pnas.1812876116","article-title":"Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells","volume":"116","author":"Kr\u00f6ger","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2022.101239_bib23","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1158\/0008-5472.CAN-14-3476","article-title":"Tracking and functional characterization of epithelial-mesenchymal transition and mesenchymal tumor cells during prostate cancer metastasis","volume":"75","author":"Ruscetti","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2022.101239_bib24","doi-asserted-by":"crossref","first-page":"103340","DOI":"10.18632\/oncotarget.21132","article-title":"Characterization of epithelial-mesenchymal transition intermediate\/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines","volume":"8","author":"Fustaino","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2022.101239_bib25","doi-asserted-by":"crossref","first-page":"e915","DOI":"10.1038\/cddis.2013.442","article-title":"An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to E-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrep.2022.101239_bib26","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/ijms12031595","article-title":"Cancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine","volume":"12","author":"Yin","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2022.101239_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrep.2022.101239_bib28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2022.101239_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.matbio.2015.03.004","article-title":"Membrane-type matrix metalloproteinases: their functions and regulations","volume":"44\u201346","author":"Itoh","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbrep.2022.101239_bib30","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrep.2022.101239_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2022.101239_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000072343","article-title":"Interleukin-1alpha enhances integrin alpha(6)beta(1) expression and metastatic capability of human pancreatic cancer","volume":"65","author":"Sawai","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.bbrep.2022.101239_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1023\/A:1024276821731","article-title":"Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas","volume":"48","author":"Sawai","year":"2003","journal-title":"Dig. Dis. Sci."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580822000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580822000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:44:22Z","timestamp":1762501462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580822000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"alternative-id":["S2405580822000395"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2022.101239","relation":{},"ISSN":["2405-5808"],"issn-type":[{"type":"print","value":"2405-5808"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGF-\u03b21 increases cellular invasion of colorectal neuroendocrine carcinoma cell line through partial epithelial-mesenchymal transition","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2022.101239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101239"}}